Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin in Early Stage ER-, PR-, HER-2 Negative Breast Cancer
NCT00148694Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jul 2004
- Primary completion
- May 2006
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in breast cancer, sponsored by Dana-Farber Cancer Institute. Started Jul 2004; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00148694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148694.